Release date: 2015-01-15 The future development of the disease database is likely to achieve certain breakthroughs, become an important means in the entire diagnosis and treatment process, and will become a force that cannot be ignored in the development of Internet medical care. For the current Chinese medical market, the entry point of the disease database can be divided into two parts. First, for the disease database of common diseases, the main function is to provide patients with self-diagnosis to help them clearly identify which type of specialist. Due to the lack of general practitioners in China, such databases can be an important reference for grassroots general practitioners in the development of general practitioners. Ordinary guidelines for general practitioners may be developed under the guidance of a doctor at a large hospital. Second, a database of cases for incurable diseases and acute illnesses. This kind of database is mainly aimed at the third- and fourth-tier cities at the grassroots level and the whole country. It is mainly open to doctors and becomes an important basis for their diagnosis. Whether it is acute or intractable, the ability of the grassroots doctor is obviously unable to control. The case database can help them make basic judgments about the patient without delaying the condition, and can also find a clear direction when conducting a remote consultation. As far as the consultation is concerned, the current passenger flow is mainly concentrated in large hospitals, whether in rural areas or in cities, all of which are flocking to large hospitals for medical treatment. This is not only caused by the weakening of primary medical care in China, but also because the entire consultation process has not established a comprehensive norm. And the guidance caused by it. In the pre- and post-diagnosis, the disease database has the greatest chance. Whether it is the patient's self-diagnosis before the consultation or the doctor's reference during the consultation, there is a great market opportunity and significance. Relatively speaking, the disease database has a much weaker meaning after diagnosis. Whether it is rehabilitation or chronic disease follow-up, it focuses on the recovery and control of the disease, and no further decision-making is needed. As far as the current medical market is concerned, it is difficult for the disease database to achieve great development in the C-end for ordinary patients. In the field of disease knowledge popularization and user self-diagnosis in China, the objectivity of information has been greatly subverted, and it is difficult for users to make accurate judgments on these true and false information. This is mainly because information providers rely mainly on advertising and it is difficult to stand on a neutral standpoint to serve users. Moreover, users have become accustomed to obtaining this information for free, and can only use the advertising model. It is difficult to achieve objective neutrality, and it is impossible to truly win the trust of users. Before the commercial insurance has not developed vigorously, it is difficult to rely on institutions to pay the bill. The dilemma of the disease database in the C-end is similar to the current network consultation. Because of the lack of basic trust and the inability to provide accurate diagnosis, it is difficult to provide real value to users. However, if such a service has a certain value as a front-end for medical treatment, combining some basic equipment to obtain preliminary user data can be used as a guide for user consultation. Therefore, the service for the C-side may be more suitable for a larger layout front-end. The investment of the giant does not depend on whether it is profitable, but to help it obtain the user-introduced back-end medical services. With the future development of primary care, the B-end disease database will be favored. China is not only weak in primary medical care, but also has weak medical strength in third- and fourth-tier cities. County-level medical institutions are in urgent need of development. But the reality is that outstanding talents are not willing to fall to the grassroots level, and users are not willing to go to the grassroots to see a doctor, which leads to a vicious circle of primary health care. To solve this dilemma, only by improving the technical ability and service level of primary medical institutions can attract patients to return to the grassroots, but it is not easy to do so. In this case, the value of the disease database is reflected. Help grassroots doctors reduce the rate of misdiagnosis by establishing a standardized database of minor and common diseases. Increasing the accuracy of the diagnosis and improving the service standards will effectively improve the patient's satisfaction rate with primary care. At the same time, it is necessary to change the image of the current outpatient clinic for primary care. By working with chain pharmacies, we can get rid of the dependence of primary care on drug revenue and solve the problem of incomplete drug list. The establishment of a database of incurable diseases and acute illnesses can help grassroots doctors respond quickly and fight for patients. Help the grassroots doctors to roughly judge the patient's condition, and find relevant experts to conduct remote consultations, not only for the effective treatment of patients, but also save time and cost. However, the establishment of the disease database will still be challenging. First of all, the establishment of this database is time-consuming and labor-intensive, how to ensure the accuracy of its standards. Whether it is a common disease or a difficult disease, it may be necessary to mobilize the resources of a famous doctor. This is not a startup company can complete. Secondly, it is very difficult to establish a database of intractable diseases and acute illnesses. Large hospitals rely on these cases to complete scientific research tasks and master the core competence of treatment. It is not easy for them to open up. Of course, if you can really share it, it is really a great benefit to society. Finally, the charging operation of the disease database is not easy. At present, the charge for the C-end is very small, and the charge for the B-end needs to establish a unified specification, and there is no problem that the pricing is too confusing. In short, the disease database has great significance for future medical reform and market development in China, but there are still multiple challenges. Source: Village Diary Basic organic raw material Shandong YingLang Chemical Co.,Ltd , https://www.sdylhgtrade.com